SALES AGENCY FINANCING AGREEMENT
Exhibit 1.3
Sales
Agency Financing Agreement (this “Agreement”), dated as of
March 10, 2010 between
BRANDYWINE REALTY TRUST, a Maryland real estate investment trust (the “Company”) and BRANDYWINE
OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (the “Operating Partnership”), and
DEUTSCHE BANK SECURITIES INC., a registered broker-dealer organized under the laws of Delaware
(“DBSI”).
W I T N E S S E T H:
WHEREAS, the Company has authorized and proposes to issue and sell in the manner contemplated
by this Agreement up to 15,000,000 Common Shares (as defined herein) upon the terms and subject to
the conditions contained herein;
WHEREAS, DBSI has been appointed by the Company as its agent to sell the Common Shares and
agrees to use its commercially reasonable efforts to sell the Common Shares offered by the Company
upon the terms and subject to the conditions contained herein; and
WHEREAS, the Company has also entered into sales agency financing agreements (each, an
“Alternative Sales Agency Agreement”), each dated of even date herewith, with each of BNY Mellon
Capital Market LLC and Citigroup Global Markets Inc. (each, an “Alternative Sales Agent”), for the
issuance and sale from time to time through the Alternative Sales Agents of Common Shares on the
terms set forth in the Alternative Sales Agency Agreements. This Agreement and the Alternative
Sales Agency Agreements are collectively referred to herein as the “Sales Agency Agreements.” The
aggregate number of Common Shares to be issued and sold pursuant to the Sales Agency Agreements
shall not exceed the Maximum Program Amount (as defined herein);
NOW THEREFORE, in consideration of the premises, representations, warranties, covenants and
agreements contained herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, intending to be legally bound hereby, the parties
hereto agree as follows:
ARTICLE I
DEFINITIONS
DEFINITIONS
Section 1.01. Certain Definitions. For purposes of this Agreement, capitalized terms
used herein and not otherwise defined shall have the following respective meanings:
“Actual Sold Amount” means the number of Issuance Shares that DBSI has sold during the Selling
Period.
“Affiliate” means, with respect to a Person, another Person that directly or indirectly,
through one or more intermediaries, controls, is controlled by, or is under common control with,
such first-mentioned Person. The term “control” (including the terms “controlling,” “controlled
by” and “under common control with”) means the possession, direct or
indirect, of the power to direct or cause the direction of the management and policies of a
Person, whether through the ownership of voting securities, by contract or otherwise.
“Alternative Sales Agency Agreement” has the meaning set forth in the Recitals.
“Alternative Sales Agents” has the meaning set forth in the Recitals.
“Applicable Time” means the time of sale of any Common Shares pursuant to this Agreement.
“Closing” has the meaning set forth in Section 2.02.
“Closing Date” means the date on which the Closing occurs.
“Comfort Letter Request Date” has the meaning set forth in Section 4.08.
“Commission” means the U.S. Securities and Exchange Commission.
“Commitment Period” means the period commencing on the date of this Agreement and expiring on
the earliest to occur of (x) the date on which DBSI and the Alternative Sales Agents in the
aggregate shall have sold the Maximum Program Amount pursuant to the Sales Agency Agreements, (y)
the date on which this Agreement is terminated pursuant to Article VII and (z) the third
anniversary of the date of this Agreement.
“Common Shares” means Common Shares of Beneficial Interest issued or issuable pursuant to the
Sales Agency Agreements.
“Common Shares of Beneficial Interest” means the common shares of beneficial interest, $0.01
par value per share, of the Company.
“Controlling Persons” has the meaning set forth in Section 6.01.
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
“Floor Price” means the minimum price per share set by the Company in the Issuance Notice
below which DBSI shall not sell Common Shares during the Selling Period, which may be adjusted by
the Company at any time during the Selling Period and which in no event shall be less than $1.00
without prior written consent of DBSI, which may be withheld in DBSI’s sole discretion.
“General Disclosure Package” has the meaning set forth in Section 3.02.
“Indemnified Party” has the meaning set forth in Section 6.03.
“Indemnifying Party” has the meaning set forth in Section 6.03.
“Intellectual Property” has the meaning set forth in Section 3.21.
-2-
“Internal Revenue Code” means the Internal Revenue Code of 1986, as amended.
“Issuance” means each occasion on which the Company elects to exercise its right to deliver an
Issuance Notice requiring DBSI to use its commercially reasonable efforts to sell the Common Shares
as specified in such Issuance Notice, subject to the terms and conditions of this Agreement.
“Issuance Date” means any Trading Day during the Commitment Period on which an Issuance Notice
is deemed delivered pursuant to Section 2.03(b) hereof.
“Issuance Notice” means a written notice to DBSI delivered in accordance with this Agreement
substantially in the form attached hereto as Exhibit A.
“Issuance Price” means the Sales Price less the Selling Commission.
“Issuance Shares” means all Common Shares of Beneficial Interest issued or issuable pursuant
to an Issuance that has occurred or may occur in accordance with the terms and conditions of this
Agreement.
“Issuance Supplement” has the meaning set forth in Section 3.01.
“Issuer Free Writing Prospectus” means any “written communication” which constitutes a “free
writing prospectus” as such terms are defined in Rule 405 under the Securities Act with respect to
the offering of Common Shares contemplated by the Sales Agency Agreements.
“Liens” has the meaning set forth in Section 3.05.
“Material Adverse Effect” means (i) a material adverse effect on the business, properties,
management, results of operations, financial condition or prospects of the Company and its
subsidiaries (including, without limitation, the Operating Partnership), taken as a whole, or (ii)
a material adverse effect on the ability to perform on the part of, or the performance by, the
Company of its obligations hereunder.
“Maximum Program Amount” means up to 15,000,000 Common Shares (or, if less, the aggregate
amount of Common Shares registered under the Registration Statement).
“Officers’ Certificate Request Date” has the meaning set forth in Section 4.09.
“Opinion Request Date” has the meaning set forth in Section 4.07.
“Original Registration Statement” has the meaning set forth in Section 3.01.
“Person” means an individual or a corporation, partnership, limited liability company, trust,
incorporated or unincorporated association, joint venture, joint stock company, governmental
authority or other entity of any kind.
-3-
“Principal Market” means, with respect to the Company’s Common Shares of Beneficial Interest,
the New York Stock Exchange.
“Prospectus” has the meaning set forth in Section 3.01.
“Prospectus Supplement” has the meaning set forth in Section 5.01(k).
“Registration Statement” has the meaning set forth in Section 3.01.
“Registration Statement Amendment Date” has the meaning set forth in Section 4.07.
“REIT” has the meaning set forth in Section 3.19.
“Request Date” means each Comfort Letter Request Date, each Officers’ Certificate Request Date
and each Opinion Request Date.
“Sales Agency Agreements” has the meaning set forth in the Recitals.
“Sales Price” means the actual sale execution price of each Common Share sold by DBSI on the
Principal Market hereunder in the case of ordinary brokers’ transactions, or as otherwise agreed by
the parties in other methods of sale.
“Xxxxxxxx-Xxxxx Act” means the Xxxxxxxx-Xxxxx Act of 2002.
“Securities Act” means the Securities Act of 1933, as amended.
“Selling Commission” means the percentage (not to exceed 2.0%) of the Sales Price of the
Common Shares sold during a Selling Period as agreed from time to time by the Company and DBSI.
“Selling Period” means the period of one to ten consecutive Trading Days (as determined by the
Company in the Company’s sole discretion and specified in the applicable Issuance Notice) following
the Trading Day on which an Issuance Notice is delivered or deemed to be delivered pursuant to
Section 2.03(b) hereof.
“Settlement Date” means, unless the Company and DBSI shall otherwise agree, the third business
day following each Trading Day during the Selling Period, when the Company shall deliver to DBSI the
amount of Common Shares sold on such Trading Day and DBSI shall deliver to the Company the Issuance
Price received on such sales.
“Trading Day” means any day which is a trading day on the New York Stock Exchange, other than
a day on which trading is scheduled to close prior to its regular weekday closing time.
-4-
ARTICLE II
ISSUANCE AND SALE OF COMMON SHARES
ISSUANCE AND SALE OF COMMON SHARES
Section 2.01. Issuance. (a) Upon the terms and subject to the conditions of this
Agreement, the Company may issue Common Shares through DBSI and DBSI shall use its commercially
reasonable efforts to sell up to 15,000,000 Common Shares, based on and in accordance with such
number of Issuance Notices as the Company in its sole discretion shall choose to deliver during the
Commitment Period until the aggregate number of Common Shares sold under the Sales Agency
Agreements equals the Maximum Program Amount or this Agreement is otherwise terminated. Subject to
the foregoing and the other terms and conditions of this Agreement, upon the delivery of an
Issuance Notice, and unless the sale of the Issuance Shares described therein has been suspended,
cancelled or otherwise terminated in accordance with the terms of this Agreement, DBSI will use its
commercially reasonable efforts consistent with its normal trading and sales practices to sell such
Issuance Shares up to the amount specified into the Principal Market, and otherwise in accordance
with the terms of such Issuance Notice. DBSI will provide written confirmation to the Company no
later than the opening of the Trading Day next following the Trading Day on which it has made sales
of Issuance Shares hereunder setting forth the portion of the Actual Sold Amount for such Trading
Day, the corresponding Sales Price and the Issuance Price payable to the Company in respect
thereof. DBSI may sell Issuance Shares in the manner described in Section 2.01(b) herein. The
Company acknowledges and agrees that (i) there can be no assurance that DBSI will be successful in
selling Issuance Shares and (ii) DBSI will incur no liability or obligation to the Company or any
other Person if it does not sell Issuance Shares for any reason other than a failure by DBSI to use
its commercially reasonable efforts consistent with its normal trading and sales practices to sell
such Issuance Shares in accordance with this Section 2.01. In acting hereunder, DBSI will be acting
as agent for the Company and not as principal.
(b) Method of Offer and Sale. The Common Shares may be offered and sold in (1)
privately negotiated transactions (if and only if the parties hereto have so agreed in writing), or
(2) by any other method or payment permitted by law deemed to be an “at the market” offering as
defined in Rule 415 of the Securities Act, including sales made directly on the Principal Market or
sales made to or through a market maker or through an electronic communications network. Nothing
in this Agreement shall be deemed to require either party to agree to the method of offer and sale
specified in clause (1) of this Section 2.03(b), and either party may withhold its consent thereto
in such party’s sole discretion.
(c) Issuances. Upon the terms and subject to the conditions set forth herein, on any
Trading Day as provided in Section 2.03(b) hereof during the Commitment Period on which the
conditions set forth in Section 5.01 hereof have been satisfied, the Company may exercise an
Issuance by the delivery of an Issuance Notice, executed by the President and Chief Executive
Officer of the Company, to DBSI. The number of Issuance Shares that DBSI shall use its commercially
reasonable efforts to sell pursuant to such Issuance shall be as specified in such Issuance Notice.
Each Issuance will be settled on the applicable Settlement Date following the Issuance Date.
Section 2.02. Effectiveness. The effectiveness of this Agreement (the “Closing”)
shall be deemed to take place concurrently with the execution and delivery of this Agreement by
-5-
the parties hereto and the completion of the closing transactions set forth in the immediately
following sentence. At the Closing, the following closing transactions shall take place, each of
which shall be deemed to occur simultaneously with the Closing: (i) the Company shall deliver to
DBSI a certificate executed by the Secretary of the Company, signing in such capacity, dated the
date of the Closing (A) certifying that attached thereto are true and complete copies of the
resolutions duly adopted by the Board of Trustees of the Company authorizing the execution and
delivery of this Agreement and the consummation of the transactions contemplated hereby (including,
without limitation, the issuance of the Common Shares pursuant to this Agreement), which
authorization shall be in full force and effect on and as of the date of such certificate and (B)
certifying and attesting to the office, incumbency, due authority and specimen signatures of each
Person who executed the Agreement for or on behalf of the Company; (ii) the Company shall deliver
to DBSI a certificate executed by the President and Chief Executive Officer and by the Executive
Vice President and Chief Financial Officer of the Company, signing in such capacity, dated the date
of the Closing, confirming that the representations and warranties of the Company contained in this
Agreement are true and correct and that the Company has performed all of it obligations hereunder
to be performed on or prior to the Closing Date and as to the matters set forth in Section 5.01(a)
hereof; (iii) Xxxxxx Xxxxxxxx LLP, counsel to the Company and the Operating Partnership, shall
deliver to DBSI an opinion, dated the Closing Date and addressed to DBSI and the Alternative Sales
Agents, substantially in the form of Exhibit B attached hereto; (iv) Xxxxxxx Xxxxxxx & Xxxxxxxx
LLP, counsel to DBSI and the Alternative Sales Agents, shall deliver an opinion and negative
assurance letter, dated the Closing Date and addressed to DBSI and the Alternative Sales Agents, as
to such matters and in form and substance reasonably satisfactory to DBSI and the Alternative Sales
Agents; (v) PricewaterhouseCoopers LLP shall deliver to DBSI and the Alternative Sales Agents a
comfort letter, dated the Closing Date, in form and substance reasonably satisfactory to DBSI and
the Alternative Sales Agents; and (vi) the Company shall pay the expenses set forth in Section
9.02(ii), (iv) and (viii) hereof by wire transfer to the account designated by DBSI in writing prior
to the Closing.
Section 2.03. Mechanics of Issuances.
(a) Issuance Notice. On any Trading Day during the Commitment Period, the Company may
deliver an Issuance Notice to DBSI, subject to the satisfaction of the conditions set forth in
Section 5.01; provided, however, that notwithstanding anything in this Agreement to the contrary,
DBSI shall have no further obligations with respect to any Issuance Notice if and to the extent the
aggregate number of Issuance Shares sold pursuant thereto, together with the aggregate number of
Common Shares previously sold under the Sales Agency Agreements, shall exceed the Maximum Program
Amount. Subject to the foregoing, the Company shall have the right, in its sole discretion, to
amend at any time and from time to time any Issuance Notice by notice to DBSI and, if so notified,
DBSI shall, as soon as practicable, modify its offers to sell consistent with any such amendment
notice; provided, however, that the Company may not amend the number of Issuance Shares if such
amended number of Issuance Shares is less than the Actual Sold Amount as of the date of such
amendment.
(b) Delivery of Issuance Notice. An Issuance Notice shall be deemed delivered on the
Trading Day that it is received by facsimile or otherwise (and the Company confirms such delivery
by e-mail notice or by telephone (including voicemail message)) by DBSI.
-6-
No Issuance Notice may be delivered other than on a Trading Day during the Commitment Period.
(c) Floor Price. DBSI shall not sell Common Shares below the Floor Price during any
Selling Period and such Floor Price may be adjusted by the Company at any time during any Selling
Period upon notice to DBSI and confirmation to the Company.
(d) Determination of Issuance Shares to be Sold. The number of Issuance Shares to be
sold by DBSI with respect to any Issuance shall be the Actual Sold Amount during the Selling Period.
(e) Trading Guidelines. DBSI may trade in Common Shares of Beneficial Interest for
DBSI’s own account and for the account of its clients at the same time as sales of Common Shares
occur pursuant to this Agreement, provided, however, that any such trading and related activity
comply with applicable federal and state laws, rules and regulations (including, without
limitation, Regulation M under the Exchange Act). In addition, the Company and the Operating
Partnership acknowledge and agree that DBSI’s affiliates may make markets in the Common Shares of
Beneficial Interest or other securities of the Company or the Operating Partnership, in connection
with which they may buy and sell, as agent or principal, for long or short account, Common Shares
of Beneficial Interest or other securities of the Company or the Operating Partnership, at the same
time that DBSI is acting as agent pursuant to this Agreement.
Section 2.04. Settlements. Subject to the provisions of Article V, on or before each
Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the
Issuance Shares being sold by crediting DBSI or its designee’s account at the Depository Trust
Company through its Deposit/Withdrawal At Custodian (DWAC) System, or by such other means of
delivery as may be mutually agreed upon by the parties hereto and, upon receipt of such Issuance
Shares, which in all cases shall be freely tradeable, transferable, registered shares in good
deliverable form, DBSI will deliver the related Issuance Price in same day funds delivered to an
account designated by the Company prior to the Settlement Date. If the Company defaults in its
obligation to deliver Issuance Shares on a Settlement Date, the Company agrees that it will (i)
hold DBSI harmless against any loss, claim, damage or expense (including, without limitation,
penalties, interest and reasonable legal fees and expenses), as incurred, arising out of or in
connection with such default by the Company, and (ii) pay to DBSI any Selling Commission to which it
would otherwise have been entitled absent such default. The parties acknowledge and agree that, in
performing its obligations under this Agreement, DBSI may borrow Common Shares of Beneficial
Interest from stock lenders, and may use the Issuance Shares to settle or close out such
borrowings.
Section 2.05. Use of Free Writing Prospectus. Neither the Company nor DBSI has
prepared, used, referred to or distributed, or will prepare, use, refer to or distribute, any
Issuer Free Writing Prospectus without the other party’s prior written consent.
Section 2.06. Alternative Sales Agents. The Company agrees that any offer to sell,
any solicitation of an offer to buy, or any sales of Common Shares or any other equity security of
the Company shall only be effected by or through only one of DBSI or the Alternative
-7-
Sales Agents on any single given day, and the Company shall in no event request that DBSI and
any other Alternative Sales Agent sell Common Shares on the same day.
Section 2.07. Material Non-Public Information. Notwithstanding any other provision
of this Agreement, DBSI shall not be obligated to sell any Common Shares hereunder during any period
in which it reasonably believes that the Company is, or may be deemed to be, in possession of
material non-public information.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
The Company and the Operating Partnership, jointly and severally, represent and warrant to,
and agree with, DBSI that as of the Closing Date, each Issuance Date, each Applicable Time, each
Settlement Date, each Registration Statement Amendment Date (as defined in Section 4.07) and each
Request Date:
Section 3.01. Registration. The Common Shares are registered pursuant to Section
12(b) of the Exchange Act and have been listed on the Principal Market, subject to notice of
issuance. The Company (i) meets the requirements for the use of Form S-3 under the Securities Act
and the rules and regulations thereunder for the registration of the transactions contemplated by
this Agreement and (ii) has been subject to the requirements of Section 12 of the Exchange Act and
has timely filed all the material required to be filed pursuant to Section 13 and 14 of the
Exchange Act for a period of more than 12 calendar months. A registration statement on Form S-3
(File No. 333-158589) (“the “Original Registration Statement”) in respect of the Common Shares has
been (i) prepared by the Company and the Operating Partnership in conformity with the requirements
of the Securities Act and the rules and regulations of the Commission thereunder, and (ii) filed
with the Commission under the Securities Act and declared effective by the Commission not earlier
than three years prior to the date hereof; no stop order suspending the effectiveness of the
registration statement or any post-effective amendment thereto, if any, has been issued, and, to
the Company’s knowledge, no proceeding for that purpose or pursuant to Section 8A of the Securities
Act has been initiated or threatened by the Commission; and the Company proposes to file or has
filed with the Commission pursuant to Rule 424(b) under the Securities Act (“Rule 424(b)”) a
prospectus supplement to the form of prospectus included in such registration statement and has
previously advised you of all information (financial and other) with respect to the Company to be
set forth therein. Such registration statement (and any further registration statements that may
be filed by the Company for the purpose of continuing the offering of the Common Shares upon
expiration of the effectiveness of the Original Registration Statement after the third anniversary
of its original effective date or for the purpose of registering additional Common Shares to be
sold pursuant to this Agreement), and the prospectus constituting part of such registration
statement, together with the Prospectus Supplement (as defined in Section 5.01(k)) and any pricing
supplement relating to a particular issuance of the Issuance Shares (each, an “Issuance
Supplement”), including all documents incorporated or deemed to be incorporated therein by
reference pursuant to Item 12 of Form S-3 under the Securities Act, in each case, as from time to
time amended or supplemented, are referred to herein as the “Registration Statement” and the
“Prospectus,” respectively, except that if any revised prospectus is provided to DBSI by the Company
for use in connection with the offering of the Common Shares that is not required to be filed by
the Company pursuant to Rule
-8-
424(b) promulgated by the Commission under the Securities Act, the term “Prospectus” shall
refer to such revised prospectus from and after the time it is first provided to DBSI for such use.
Promptly after the execution and delivery of this Agreement, the Company will prepare and file the
Prospectus Supplement relating to the Issuance Shares pursuant to Rule 424(b) promulgated by the
Commission under the Securities Act, as contemplated by Section 5.01(k) of this Agreement. As used
in this Agreement, the terms “amendment” or “supplement” when applied to the Registration Statement
or the Prospectus shall be deemed to include the filing by the Company with the Commission of any
document under the Exchange Act after the date hereof that is or is deemed to be incorporated
therein by reference.
Section 3.02. Registration Statement and Prospectus. The Registration Statement
conforms, and the Prospectus Supplement and any further amendments or supplements to the
Registration Statement or the Prospectus will conform, in all material respects to the
requirements of the Securities Act and the rules and regulations of the Commission thereunder, the
Registration Statement and any amendment thereto do not and will not, as of the applicable
effective date or dates, contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein not
misleading; and the Prospectus (and any amendment or supplement thereto) and the applicable Issuer
Free Writing Prospectus(es), if any, issued at or prior to the Applicable Time, taken together
(collectively, and, with respect to any Common Shares, together with the public offering price of
such Common Shares, the “General Disclosure Package”) as of each Applicable Time and the Closing
Date, as the case may be, will not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; provided that the
Company makes no representation and warranty with respect to any statements or omissions made in
reliance upon and in conformity with information relating to DBSI furnished to the Company in
writing by DBSI expressly for use in the Registration Statement, the Prospectus and the General
Disclosure Package and any amendment or supplement thereto.
Section 3.03. Incorporated Documents. The documents incorporated by reference in the
Registration Statement, the Prospectus and the General Disclosure Package, when they became effective or were filed with the Commission, as the case may be,
conformed in all material respects to the requirements of the Securities Act or the Exchange Act,
as applicable, and none of such documents contained any untrue statement of a material fact or,
taken together, omitted to state a material fact required to be stated therein or necessary to make
the statements therein, in the light of the circumstances under which they were made not
misleading; and any further documents so filed and incorporated by reference in the Registration
Statement, the Prospectus and the General Disclosure Package, when such documents become effective
or are filed with the Commission, as the case may be, will conform in all material respects to the
requirements of the Securities Act or the Exchange Act, as applicable, and will not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein, in the light of the circumstances under which they
were made, not misleading.
Section 3.04. Formation, Power and Authority of Company and the Operating
Partnership. The Company has been duly formed and is validly existing as a real estate
investment trust in good standing under the laws of the State of Maryland, with trust power and
-9-
authority to own its properties and conduct its business as described in the Registration
Statement, the Prospectus and the General Disclosure Package, and has been duly qualified or
registered as a foreign real estate investment trust for the transaction of business and is in good
standing or subsisting under the laws of each other jurisdiction in which it owns or leases
properties or conducts any business so as to require such qualification or registration except
where the failure to so qualify or register or be in good standing or subsisting could not
reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect; the
Operating Partnership has been duly formed and is validly existing as a limited partnership in good
standing under the laws of the State of Delaware, with partnership power and authority to own its
properties and conduct its business as described in the Registration Statement, the Prospectus and
the General Disclosure Package, and has been duly qualified or registered as a foreign limited
partnership for the transaction of business and is in good standing or subsisting under the laws of
each other jurisdiction in which it owns or leases properties or conducts any business so as to
require such qualification or registration except where the failure to so qualify or register or be
in good standing or subsisting could not reasonably be expected, individually or in the aggregate,
to have a Material Adverse Effect; and each other subsidiary of the Company has been duly
incorporated, formed or organized and is validly existing as a corporation or other entity in good
standing or subsisting under the laws of its jurisdiction of incorporation, formation or
organization, with corporate, partnership or limited liability company power and authority to own
its properties and conduct its business as described in the Registration Statement, the Prospectus
and the General Disclosure Package, and has been duly qualified or registered as a foreign
corporation or other foreign entity for the transaction of business and is in good standing or
subsisting under the laws of each other jurisdiction in which it owns or leases properties or
conducts any business so as to require such qualification or registration except where the failure
to so qualify or register or be in good standing or subsisting could not reasonably be expected,
individually or in the aggregate, to have a Material Adverse Effect.
Section 3.05. Capitalization. The Company has an authorized capitalization as set
forth in the Registration Statement, the Prospectus and the General Disclosure Package, and all of
the issued Common Shares of Beneficial Interests have been duly and validly authorized and issued
and are fully paid; except as set forth in the Registration Statement, the Prospectus and the
General Disclosure Package, all of the issued shares of capital stock, partnership, membership or
beneficial interests of each consolidated subsidiary (including, without limitation, the Operating
Partnership) have been duly and validly authorized and issued, are fully paid and, if applicable,
non-assessable and are owned directly or indirectly by the Company, free and clear of all liens,
encumbrances or claims (collectively, “Liens”); and the Company is the sole general partner of the
Operating Partnership and its ownership percentage in the Operating Partnership is as set forth in
the Registration Statement, the Prospectus and the General Disclosure Package as of the date
thereof.
Section 3.06. Financial Statements. Except as noted therein, the consolidated
financial statements (including the related notes thereto) incorporated by reference in the
Registration Statement, the Prospectus and the General Disclosure Package present fairly, in all
material respects, the consolidated financial condition of the Company and its consolidated
subsidiaries (including without limitation the Operating Partnership) as of the dates indicated and
the results of their operations and changes in their consolidated cash flows for the periods
specified; such financial statements have been prepared in conformity with accounting principles
-10-
generally accepted in the United States applied on a consistent basis; any supporting
schedules incorporated by reference in the Registration Statement present fairly in all material
respects the information required to be stated therein; and any pro forma financial information
(including the related notes thereto) contained or incorporated by reference in the Registration
Statement, the Prospectus and the General Disclosure Package presents fairly in all material
respects the information contained therein and have been prepared on a reasonable basis using
reasonable assumptions and in accordance with the applicable requirements of the Securities Act and
the Exchange Act.
Section 3.07. Internal Controls.
(a) The Company and its consolidated subsidiaries (including, without limitation, the
Operating Partnership) maintain a system of internal accounting controls sufficient to provide
reasonable assurance that (i) transactions are executed in accordance with management’s general or
specific authorizations; (ii) transactions are recorded as necessary to permit preparation of
financial statements in conformity with generally accepted accounting principles and to maintain
asset accountability; (iii) access to assets is permitted only in accordance with management’s
general or specific authorization; and (iv) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action is taken with respect to any
differences.
(b) Since the end of the most recent audited fiscal year, there has been (i) no material
weakness in the Company’s internal control over financial reporting (whether or not remediated) and
(ii) no change in the Company’s internal control over financial reporting that has materially
affected, or is reasonably likely to materially affect, the Company’s internal control over
financial reporting.
(c) The Company and its consolidated subsidiaries employ disclosure controls and procedures
that are designed to ensure that information required to be disclosed by the Company in the
reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported,
within the time periods specified in the Commission’s rules and forms, and is accumulated and
communicated to the Company’s management, including its principal executive officer and principal
financial officer, as appropriate, to allow timely decisions regarding disclosure.
Section 3.08. Independent Registered Public Accounting Firm. PricewaterhouseCoopers
LLP, the independent registered public accounting firm of the Company and the Operating
Partnership, which has audited certain financial statements of the Company and its consolidated
subsidiaries and of the Operating Partnership and its consolidated subsidiaries, is an independent
registered public accounting firm with respect thereto as required by the Securities Act and the
rules and regulations of the Commission and the Public Company Accounting Oversight Board.
Section 3.09. Common Shares. The Common Shares have been duly authorized and, when
issued and delivered in accordance with the terms of this Agreement, will be validly issued, fully
paid and non-assessable, and the issuance of such Common Shares will not be subject to preemptive
or other rights afforded by the Company to subscribe for the Common
-11-
Shares. Upon issuance, the Common Shares will conform in all material respects to the
statements relating thereto contained in the Registration Statement, the Prospectus and the General
Disclosure Package. Upon payment of the purchase price and delivery of the Common Shares in
accordance with this Agreement, each of the purchasers thereof will receive good, valid and
marketable title to such Common Shares, free and clear of all liens, charges and encumbrances.
Section 3.10. Sale of Common Shares. Immediately after any sale of Common Shares by
the Company hereunder, the aggregate amount of Common Shares of Beneficial Interest that have been
issued and sold by the Company under the Registration Statement, including the Common Shares sold
hereunder, will not exceed the aggregate amount of such shares registered under the Registration
Statement (in this regard, the Company acknowledges and agrees that DBSI shall have no
responsibility for maintaining records with respect to the aggregate amount of Common Shares sold,
or of otherwise monitoring the availability of Common Shares of Beneficial Interest for sale, under
the Registration Statement).
Section 3.11. Agreement. This Agreement has been duly authorized, executed and
delivered by the Company and the Operating Partnership.
Section 3.12. No Violation. Neither the Company nor any of its subsidiaries
(including, without limitation, the Operating Partnership) is, or with the giving of notice or
lapse of time or both would be, in violation of or in default under its declaration of trust,
charter, by-laws, partnership agreement, operating agreement or other organizational documents, as
applicable, except where, in the case of any subsidiary that is not the Operating Partnership, the
violation or default could not reasonably be expected, individually or in the aggregate, to have a
Material Adverse Effect, or any indenture, mortgage, deed of trust, loan agreement or other
agreement or instrument to which the Company or any of its subsidiaries (including, without
limitation, the Operating Partnership) is a party or by which it or any of them or any of their
respective properties is bound, except where the violation or default could not reasonably be
expected, individually or in the aggregate, to have a Material Adverse Effect; the issue and sale
of the Common Shares, the compliance by the Company with all of the provisions of this Agreement,
and the consummation of the transactions herein contemplated will not conflict with or result in a
breach or violation of any of the terms or provisions of, or constitute a default under, any
indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the
Company or any of its subsidiaries (including, without limitation, the Operating Partnership) is a
party or by which the Company or any of its subsidiaries (including, without limitation, the
Operating Partnership) is bound or to which any of the property or assets of the Company or any of
its subsidiaries (including, without limitation, the Operating Partnership) is subject, nor will
such actions result in any violation of the provisions of the declaration of trust or the bylaws of
the Company, certificate of limited partnership or partnership agreement of the Operating
Partnership or any law, statute or any order, rule or regulation of any court or governmental
agency or body having jurisdiction over the Company or any of its subsidiaries (including, without
limitation, the Operating Partnership) or any of their properties; and no consent, approval,
authorization, order, registration or qualification of or with any court or governmental agency or
body is required for the issue and sale of the Common Shares or the consummation by the Company of
the other transactions contemplated by this Agreement, except such as have been obtained under the
Securities Act and such consents, approvals, authorizations,
-12-
orders, registrations or qualifications as may be required under state securities or Blue Sky
laws in connection with the purchase and distribution of the Common Shares by DBSI.
Section 3.13. No Material Adverse Change; Changes in Beneficial Interest. The
Company and its subsidiaries (including, without limitation, the Operating Partnership), taken as a
whole, have not sustained since the date of the latest audited financial statements included or
incorporated by reference in the Registration Statement and the Prospectus any material loss or
interference with its business from fire, explosion, flood or other calamity, whether or not
covered by insurance, or from any labor dispute or court or governmental action, order or decree,
except as set forth in the Registration Statement and the Prospectus; and, since the respective
dates as of which information is given in the Registration Statement and the Prospectus, (i) there
has not been any change in the shares of beneficial interests of the Company (other than (x)
issuances of beneficial interests (A) pursuant to equity-based awards granted in the ordinary
course of business to trustees or employees of the Company or the Operating Partnership, (B) upon
exercise of options or warrants and upon conversion or redemption of convertible or redeemable
securities, in each case which were granted pursuant to clause (A) above or were outstanding as of
the date of the latest audited or unaudited financial statements included or incorporated by
reference in the Registration Statement and the Prospectus, (C) upon the exchange of Operating
Partnership interests for beneficial interests in the Company or upon exchange of any of the 3.875%
exchangeable guaranteed notes due 2026 issued by the Operating Partnership, and (D) upon issuances
of Common Shares pursuant to this Agreement or any Alternative Sales Agency Agreement, and (y)
repurchases of the Company’s shares of beneficial interests under the Company’s share repurchase
program) or in the partnership interests in the Operating Partnership (other than in connection
with any of the issuances, exercises, exchanges or repurchases covered in the foregoing clauses (x)
and (y)), or any material change in the long-term debt of the Company and its consolidated
subsidiaries (including, without limitation, the Operating Partnership), taken as a whole, and (ii)
there has not been any material adverse change in the business, properties, management, results of
operations, financial condition or prospects of the Company and its subsidiaries (including,
without limitation, the Operating Partnership), taken as a whole, except as set forth in the
Registration Statement, the Prospectus and the General Disclosure Package.
Section 3.14. Not an Investment Company. Neither the Company nor the Operating
Partnership is, and after giving effect to each offering and sale of the Common Shares is, or will
be required to register as, an “investment company” under the Investment Company Act of 1940, as
amended.
Section 3.15. No Material Actions or Proceedings. Except as set forth in the
Registration Statement, the Prospectus and the General Disclosure Package, there are no legal or
governmental proceedings pending to which the Company or any of its subsidiaries (including,
without limitation, the Operating Partnership) is a party or to which any property of the Company
or any of its subsidiaries (including, without limitation, the Operating Partnership) is subject,
which could reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect, and, to the Company’s knowledge, no such proceedings are threatened or contemplated by
governmental authorities or threatened by others.
-13-
Section 3.16. Licenses, Certificates, Permits, Etc. The Company and its subsidiaries
(including, without limitation, the Operating Partnership) possess all licenses, certificates,
permits and other authorizations issued by the appropriate federal, state, local or foreign
regulatory authorities necessary to conduct their respective businesses, and neither the Company
nor any such subsidiary has received any notice of proceedings relating to the revocation or
modification of any such license, certificate, authorization or permit which, individually or in
the aggregate, if the subject of an unfavorable decision, ruling or finding, could reasonably be
expected to have a Material Adverse Effect on the Company and its subsidiaries (including, without
limitation, the Operating Partnership), taken as a whole.
Section 3.17. No Price Stabilization or Manipulation. The Company has not taken nor
will it take, directly or indirectly any action designed to, or that might reasonably be expected
to, cause or result in manipulation of the price of the Common Shares.
Section 3.18. No Labor Disputes. No labor dispute or disturbance involving the
employees of the Company or any of its subsidiaries (including, without limitation, the Operating
Partnership) or of any other entity exists or, to the knowledge of the Company, is threatened or
imminent that could reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect.
Section 3.19. Compliance With Environmental Laws. The Company and its subsidiaries
(including, without limitation, the Operating Partnership) (A) are in compliance with applicable
federal, state, local and foreign laws and regulations relating to the protection of human health
and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants
(“Environmental Laws”), (B) have received, and are in compliance with, all permits, licenses or
other approvals required of them under applicable Environmental Laws to conduct their respective
businesses and (C) have not received notice of any actual or potential liability under any
environmental law, except in each case where such non-compliance with Environmental Laws, failure
to receive or comply with required permits, licenses or other approvals, or liability could not
reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect except
as set forth in the Registration Statement, the Prospectus and the General Disclosure Package;
except as set forth in the Registration Statement, the Prospectus and the General Disclosure
Package, neither the Company nor any of its subsidiaries (including, without limitation, the
Operating Partnership) has been named as a “potentially responsible party” under the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980, as amended; in the ordinary course
of its business, the Company periodically reviews the effect of Environmental Laws on the business,
operations and properties of the Company and its subsidiaries including the Operating Partnership,
in the course of which they identify and evaluate associated costs and liabilities (including,
without limitation, any capital or operating expenditures required for clean-up, closure of
properties or compliance with Environmental Laws, or any permit, license or approval, any related
constraints on operating activities and any potential liabilities to third parties); and on the
basis of such review, the Company has reasonably concluded that such associated costs and
liabilities could not reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect, except as set forth in the Registration Statement, the Prospectus and the General
Disclosure Package.
-14-
Section 3.20. REIT Status. At all times commencing with the Company’s taxable year
ended December 31, 1986, the Company has been, and after giving effect to the offering and the sale
of the Common Shares will continue to be, organized and operated in conformity with the
requirements for qualification of the Company as a real estate investment trust (“REIT”) under the
Code, and the proposed method of operation of the Company will enable the Company to continue to
meet the requirements for qualification and taxation as a REIT under the Code.
Section 3.21. Title to Personal Property. The Company and its subsidiaries
(including, without limitation, the Operating Partnership) have good and marketable title in fee
simple to, or have valid rights to lease or otherwise use, all items of real and personal property
that are material to their respective businesses, in each case free and clear of all Liens except
(A) those Liens which have been reflected generally or in the aggregate in the financial statements
of the Company and of the Operating Partnership as disclosed in the Registration Statement, the
Prospectus and the General Disclosure Package or as are described specifically, generally or in the
aggregate in the Registration Statement, the Prospectus and the General Disclosure Package, or (B)
such Liens not required by generally accepted accounting principles to be disclosed in the
financial statements of the Company or of the Operating Partnership, which do not (a) materially
adversely interfere with the use made or proposed to be made of such property by the Company and
its subsidiaries (including, without limitation, the Operating Partnership) or (b) could not
reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.
Section 3.22. Title to Intellectual Property. The Company and its subsidiaries
(including, without limitation, the Operating Partnership) own or possess, or can acquire on
reasonable terms, the trademarks, service marks, trade names, or other intellectual property
(collectively, “Intellectual Property”) necessary to carry on the business now operated by them,
taken as a whole, and no such entity has received any notice or is otherwise aware of any
infringement of or conflict with asserted rights of others with respect to any Intellectual
Property or of any facts or circumstances which would render any Intellectual Property invalid or
inadequate to protect the interest of such entities therein, and which infringement, conflict,
invalidity or inadequacy could reasonably be expected, individually or in the aggregate, to have a
Material Adverse Effect.
Section 3.23. No Undisclosed Relationships. No relationship (direct or indirect)
exists between or among any of the Company or any affiliate of the Company, on the one hand, and
any trustee, officer, shareholder, tenant, customer or supplier of the Company or any affiliate of
the Company, on the other hand, which is required by the Securities Act and the rules and
regulations of the Commission thereunder to be described in the Registration Statement, the
Prospectus and the General Disclosure Package which is not so described or is not described as
required; and there are no outstanding loans, advances (except normal advances for business
expenses in the ordinary course of business) or guarantees of indebtedness by the Company to or for
the benefit of any of the trustees or officers of the Company or any of their respective family
members.
Section 3.24. Taxes. The Company and its subsidiaries (including, without
limitation, the Operating Partnership) (A) have filed all federal, state, local and foreign tax
returns that are required to be filed or have requested extensions thereof except in any case in
which the failure so to file could not reasonably be expected, individually or in the aggregate, to
-15-
have a Material Adverse Effect, and (B) have paid all taxes required to be paid by them and
any other assessment, fine or penalty levied against them, to the extent that any of the foregoing
is due and payable, except for any such assessment, fine or penalty that is currently being
contested in good faith or as could not reasonably be expected, individually or in the aggregate,
to have a Material Adverse Effect.
Section 3.25. Compliance With ERISA. The minimum funding standard under Section 302
of the Employee Retirement Income Security Act of 1974, as amended, and the regulations and
published interpretations thereunder (“ERISA”), has been satisfied by each “pension plan” (as
defined in Section 3(2) of ERISA) which has been established or maintained by the Company and/or
one or more of its subsidiaries (including, without limitation, the Operating Partnership), and the
trust forming part of each such plan which is intended to be qualified under Section 401 of the
Code is so qualified; each of the Company and its subsidiaries (including, without limitation, the
Operating Partnership) has fulfilled its obligations, if any, under Section 515 of ERISA; except as
set forth in the Registration Statement, the Prospectus and the General Disclosure Package, neither
the Company nor any of its subsidiaries (including, without limitation, the Operating Partnership)
maintains or is required to contribute to a “welfare plan” (as defined in Section 3(1) of ERISA)
which provides retiree or other post-employment welfare benefits or insurance coverage (other than
“continuation coverage” (as defined in Section 602 of ERISA)); each pension plan and welfare plan
established or maintained by the Company and/or one or more of its subsidiaries (including, without
limitation, the Operating Partnership) is in compliance in all material respects with the currently
applicable provisions of ERISA; neither the Company nor any of its subsidiaries (including, without
limitation, the Operating Partnership) has incurred or could reasonably be expected to incur any
withdrawal liability under Section 4201 of ERISA, any liability under Section 4062, 4063, or 4064
of ERISA, or any other liability under Title IV of ERISA; and the assets of the Company and its
subsidiaries (including, without limitation, the Operating Partnership) do not constitute “plan
assets” under ERISA.
Section 3.26. Insurance. The Company and each of its subsidiaries (including,
without limitation, the Operating Partnership) are insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as are prudent and customary in
the businesses in which they are engaged; to the knowledge of the Company and its subsidiaries
(including, without limitation, the Operating Partnership) all policies of insurance insuring the
Company and its subsidiaries (including, without limitation, the Operating Partnership) or their
respective businesses, assets, trustees, directors, officers and employees are in full force and
effect; the Company and its subsidiaries (including, without limitation, the Operating Partnership)
are in compliance with the terms of such policies and instruments in all material respects; neither
the Company nor any of its subsidiaries (including, without limitation, the Operating Partnership)
has received notice from any insurer or agent of such insurer that capital improvements or other
expenditures are required or necessary to be made in order to continue such coverage; and neither
the Company nor any of its subsidiaries (including, without limitation, the Operating Partnership)
has any reason to believe that it will not be able to renew its existing insurance coverage as and
when such coverage expires or to obtain similar coverage from similar insurers as may be necessary
to continue its business at a cost that could not reasonably be expected, individually or in
aggregate, to have a Material Adverse Effect.
-16-
Section 3.27. No Restrictions on Subsidiaries. No subsidiary of the Company is
currently prohibited, directly or indirectly, from paying any dividends to the Company, from making
any other distribution on such subsidiary’s capital stock or other equity interests, from repaying
to the Company any loans or advances to such subsidiary from the Company or from transferring any
of such subsidiary’s properties or assets to the Company or any other subsidiary of the Company,
except for (i) in the case of subsidiaries of the Company that are joint ventures, the relevant
joint venture agreements may require the consent of their respective joint venture partners as a
condition to making such payment or transfers, and (ii) following an event of default under loan
documents encumbering properties owned by a subsidiary of the Company (including, without
limitation, the Operating Partnership) such subsidiary may be prohibited from making distributions
to the Company.
Section 3.28. Statistical and Market Data. The statistical and market-related data,
if any, included in the Registration Statement, the Prospectus and the General Disclosure Package
is based on or derived from sources which the Company believes, in good faith, to be reliable and
accurate in all material respects.
Section 3.29. Xxxxxxxx-Xxxxx Act. There is, and has been, no failure on the part of
the Company and its subsidiaries (including, without limitation, the Operating Partnership), and
any of their respective trustees, directors or officers in their capacities as such, to comply with
any provision of the Xxxxxxxx-Xxxxx Act of 2002 and the rules and regulations promulgated in
connection therewith, including, without limitation, Section 402 (relating to loans) and Sections
302 and 906 (relating to certifications).
Section 3.30. ADA Compliance. The Company and its subsidiaries (including, without
limitation, the Operating Partnership) are currently in compliance with all presently applicable
provisions of the Americans with Disabilities Act, as amended, except for any such non-compliance
that could not reasonably be expected, individually or in aggregate, to have a Material Adverse
Effect.
Section 3.31. Partnership Classification. The Operating Partnership and each of the
consolidated subsidiaries of the Operating Partnership that are partnerships are properly
classified as partnerships, and not as corporations or as associations taxable as corporations, for
federal income tax purposes throughout the period from their respective dates of formation through
the date hereof, or, in the case of any such partnerships that have terminated, through the date of
termination of such partnerships.
Section 3.32. Officers’ Certificates. Any certificate signed by any officer of the
Company or the Operating Partnership and delivered to DBSI or to counsel for DBSI in connection with
an Issuance shall be deemed a representation and warranty by the Company or the Operating
Partnership, as the case may be, to DBSI as to the matters covered thereby on the date of such
certificate.
For purposes of this Section 3, references to “subsidiaries”, insofar as such references relate to
entities in which the Company or Operating Partnership own or hold an equity or equivalent interest
equal to or less than 50%, are made by the Company and Operating Partnership to their knowledge
(after due inquiry).
-17-
ARTICLE IV
COVENANTS
COVENANTS
The Company covenants and agrees during the term of this Agreement with DBSI as follows:
Section 4.01. Registration Statement and Prospectus. The Company shall (i) make no
amendment or supplement to the Registration Statement or the Prospectus after the date of delivery
of an Issuance Notice and prior to the related Settlement Date without having afforded DBSI a
reasonable opportunity to review and comment thereon (other than by means of a Current Report on
Form 8-K filed with the Commission under the Exchange Act and incorporated or deemed incorporated
by reference in the Registration Statement or the Prospectus; provided, that the Company will give
prior written notice to DBSI of the intention to file such report and describe the subject matter to
be included in such report or, to the extent practicable in the circumstances, provide a draft of
such report as soon as reasonably practicable prior to the filing of
such report and afford DBSI a
reasonable opportunity to review and discuss such report prior to filing); (ii) prepare, with
respect to any Issuance Shares to be sold pursuant to this Agreement, an Issuance Supplement with
respect to such Common Shares in a form previously approved by DBSI and to file such Issuance
Supplement pursuant to Rule 424(b) promulgated by the Commission under the Securities Act within
the time period required thereby and to deliver such number of copies of each Issuance Supplement
to each exchange or market on which such sales were effected, in each case unless delivery and
filing of such an Issuance Supplement is not required by applicable law or by the rules and
regulations of the Commission; (iii) make no amendment or supplement to the Registration Statement
or the Prospectus (other than (x) an amendment or supplement relating solely to the issuance or
offering of securities other than the Common Shares issued or issuable pursuant to the Sales Agency
Agreements or (y) by means of an Annual Report on Form 10-K, a Quarterly Report on Form 10-Q, a
Current Report on Form 8-K or a Registration Statement on Form 8A or any amendments to any of the
foregoing filed with the Commission under the Exchange Act and incorporated or deemed incorporated
by reference into the Registration Statement or the Prospectus except to the extent required by
Section 4.01(i)) without having afforded DBSI a reasonable opportunity to review and comment thereon
prior to filing; (iv) file within the time periods required by the Exchange Act all reports and any
definitive proxy or information statements required to be filed by the Company or the Operating
Partnership with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act
for so long as the delivery of a prospectus is required under the Securities Act or under the blue
sky or securities laws of any jurisdiction in connection with the offering or sale of the Common
Shares, and during such same period advise DBSI, promptly after the Company receives notice thereof,
of (A) the time when any amendment to the Registration Statement has been filed or has become
effective or any prospectus supplement to the Prospectus or any amended Prospectus has been filed
with the Commission, in each case relating to the Common Shares to be sold pursuant to the Sales
Agency Agreements, (B) the issuance by the Commission of any stop order or of any order preventing
or suspending the use of any prospectus relating to such Common Shares, (C) the suspension of the
qualification of such Common Shares for offering or sale in any jurisdiction, or the initiation or
threatening of any proceeding for any such purpose, or (D) any request by the Commission for the
amending or supplementing of the Registration Statement or Prospectus or for additional
information, or the receipt of any comments from the Commission with respect to the Registration
Statement or the Prospectus
-18-
(including,
without limitation, any documents incorporated by reference); and (v) in the event of the
issuance of any such stop order or of any such order preventing or suspending the use of any
prospectus relating to the Common Shares or suspending any such qualification during a Selling
Period, promptly use its commercially reasonable efforts to obtain the withdrawal of such order; in
the event any such stop order or such other order is issued outside a Selling Period, the Company
will promptly advise DBSI as to the issuance thereof and as to whether the Company intends to seek
to obtain its withdrawal.
If, immediately prior to the third anniversary of the filing of the Original Registration
Statement, any of the Common Shares remain unsold hereunder, the Company will, prior to such third
anniversary, advise DBSI as to whether it intends to file (unless it has already done so) a new
shelf registration statement (which may include an automatic shelf registration statement) relating
to the Common Shares.
Section 4.02. Blue Sky. The Company shall use its commercially reasonable efforts to
cause the Common Shares to be listed on the Principal Market and promptly from time to time to take
such action as DBSI may reasonably request to cooperate with DBSI in the qualification of the Common
Shares for offering and sale under the blue sky or securities laws of such jurisdictions within the
United States of America and its territories as DBSI may reasonably request and use its commercially
reasonable efforts to comply with such laws so as to permit the continuance of sales and dealings
therein for as long as may be necessary to complete the sale of the Common Shares; provided,
however, that in connection therewith the Company shall not be required to qualify as a foreign
corporation, to file a general consent to service of process or to subject itself to taxation in
respect of doing business in any jurisdiction;
Section 4.03. Copies of Registration Statement and Prospectus. The Company shall
furnish DBSI with copies (which may be electronic copies) of the Registration Statement and each
amendment thereto, except where such reports, communications, financial statements or other
information is available on the Commission’s Electronic Data Gathering Analysis and Retrieval
(“XXXXX”) system,, and with copies of the Prospectus and each amendment or supplement thereto in
the form in which it is filed with the Commission pursuant to the Securities Act or Rule 424(b)
promulgated by the Commission under the Securities Act, both in such quantities as DBSI may
reasonably request from time to time; and, if the delivery of a prospectus is required under the
Securities Act or under the blue sky or securities laws of any jurisdiction at any time on or prior
to the applicable Settlement Date for any Selling Period in connection with the offering or sale of
the Common Shares and if at such time any event has occurred as a result of which the Prospectus as
then amended or supplemented would include an untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made when such Prospectus is delivered, not misleading, or, if
for any other reason it is necessary during such same period to amend or supplement the Prospectus
or to file under the Exchange Act any document incorporated by reference in the Prospectus in order
to comply with the Securities Act or the Exchange Act, the Company shall notify DBSI and request DBSI
to suspend offers to sell Common Shares (and, if so notified, DBSI shall cease such offers as soon
as practicable); and if the Company decides to amend or supplement the Registration Statement or
the Prospectus as then amended or supplemented, the Company shall advise DBSI promptly by telephone
(with confirmation in writing) and prepare and cause to be filed promptly with the Commission an
-19-
amendment or supplement to the Registration Statement or the Prospectus as then amended or
supplemented that will correct such statement or omission or effect such compliance; provided,
however, that if during such same period DBSI is required to deliver a prospectus in respect of
transactions in the Common Shares, the Company shall promptly prepare and file with the Commission
such an amendment or supplement;
Section 4.04. Rule 158. The Company shall make generally available to its holders of
the Common Shares as soon as practicable, but in any event not later than eighteen months after the
effective date of the Registration Statement (as defined in Rule 158(c) promulgated by the
Commission under the Securities Act), an earnings statement of the Company and its consolidated
subsidiaries (which need not be audited) complying with Section 11(a) of the Securities Act and the
rules and regulations of the Commission promulgated thereunder (including the option of the Company
to file periodic reports in order to make generally available such earnings statement, to the
extent that it is required to file such reports under Section 13 or Section 15(d) of the Exchange
Act, pursuant to Rule 158 promulgated by the Commission under the Securities Act);
Section 4.05. Information. Except where such reports, communications, financial
statements or other information is available on XXXXX, the Company shall furnish to DBSI (in paper
or electronic format) copies of all publicly available reports or other communications (financial
or other) furnished generally to shareholders and filed with the Commission pursuant to the
Exchange Act, and deliver to DBSI (in paper or electronic format) (i) promptly after they are
available, copies of any publicly available reports and financial statements furnished to or filed
with the Commission or the Principal Market or any other national securities exchange on which any
class of securities of the Company is listed; and (ii) such additional publicly available
information concerning the business, properties, management, results of operations, financial
condition or prospects of the Company and its subsidiaries (including, without limitation, the
Operating Partnership) taken as a whole as DBSI may from time to time reasonably request (such
financial statements to be on a consolidated basis to the extent the accounts of the Company and
its subsidiaries are consolidated in reports furnished to its shareholders generally or to the
Commission);
Section 4.06. Representations and Warranties. At each delivery of an Issuance
Notice, each Applicable Time, each Settlement Date, each Registration Statement Amendment Date (as
defined in Section 4.07) and each Request Date, (i) the Company shall be deemed to have affirmed
that each representation, warranty, covenant and other agreement contained in this Agreement is
true and correct, as though made at and as of each such date, except as may be disclosed in the
Prospectus (including any documents incorporated by reference therein and supplements thereto), and
(ii) the Company will undertake to advise DBSI if any of such representations and warranties will
not be true and correct as of each such date, as though made at and as of each such date (except
that such representations and warranties shall be deemed to relate to the Registration Statement
and the Prospectus as amended and supplemented relating to such Common Shares);
Section 4.07. Opinions of Counsel. (i) Prior to or at the first delivery of an
Issuance Notice, and each time the Registration Statement or the Prospectus is amended or
supplemented (other than by means of (x) an amendment or supplement relating solely to the
-20-
offering of securities other than the Common Shares issued or issuable pursuant to the Sales
Agency Agreements, or (y) a Current Report on Form 8-K, unless, filed during a Selling Period and
reasonably requested by DBSI within five days of the filing thereof with the Commission), including
by means of an Annual Report on Form 10-K or a Quarterly Report on Form 10-Q filed with the
Commission under the Exchange Act and incorporated or deemed to be incorporated by reference into
the Prospectus (each such date, a “Registration Statement Amendment Date”) or (ii) otherwise after
each reasonable request by DBSI (each date of any such request by DBSI, an “Opinion Request Date”),
the Company shall as soon as practicable thereafter furnish or cause to be furnished to DBSI a
written opinion of Xxxxxx Xxxxxxxx LLP, counsel for the Company, dated the date of such amendment,
supplement or incorporation and in form reasonably satisfactory to DBSI, (i) if such counsel has
previously furnished an opinion to the effect set forth in Exhibit B hereto, to the effect that DBSI
may rely on such previously furnished opinion of such counsel to the same extent as though they
were dated the date of such letter authorizing reliance (except that the statements in such last
opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended and
supplemented to such date) or (ii) if such counsel has not previously furnished an opinion to the
effect set forth in Exhibit B hereto, of the same tenor as such opinion of such counsel but
modified to relate to the Registration Statement, the Prospectus and the General Disclosure Package
(other than the offering price of any Common Shares) as amended and supplemented to such date;
provided, however, that the Company shall have the right in its sole discretion to suspend the
delivery of all such opinions otherwise required by this Section 4.07 if the Company does not
expect to deliver an Issuance Notice with respect to the Common Shares; and provided, further, that
the delivery of each such opinion (dated on or prior to the date of
such Issuance Notice) shall be a condition
precedent to the delivery by the Company of an Issuance Notice with respect to the Common Shares;
Section 4.08. Comfort Letters. (i) Prior to or at the first delivery of an Issuance
Notice, and each time the Registration Statement or the Prospectus is amended or supplemented,
including by means of an Annual Report on Form 10-K, a Quarterly Report on Form 10-Q or a Current
Report on Form 8-K (but only a Current Report on Form 8-K that contains financial statements or
financial information of the Company filed with the Commission under the Exchange Act and
incorporated or deemed to be incorporated by reference into the Prospectus), other than by an
amendment or supplement relating solely to the offering of securities other than the Common Shares
issued or issuable pursuant to the Sales Agency Agreements, in any case to set forth financial
statements or financial information included in or derived from the Company’s financial statements
or accounting records or (ii) otherwise after each reasonable request by DBSI (each date of any such
request by DBSI, a “Comfort Letter Request Date”), the Company shall as soon as practicable
thereafter cause the independent registered public accounting firm who has audited the financial
statements of the Company included or incorporated by reference in the Registration Statement to
furnish as promptly as practicable thereafter to DBSI a letter, dated the date of such amendment,
supplement or incorporation, as the case may be, in form reasonably satisfactory to DBSI, of the
same tenor as the letter referred to in Section 5.01(g) hereof but modified to relate to the
Registration Statement, the Prospectus and, to the extent applicable, the General Disclosure
Package (other than the offering price of any Common Shares) as amended or supplemented to the date
of such letter, with such changes as may be necessary to reflect changes in the financial
statements and other information derived from the accounting records of the Company, to the extent
such financial statements and other information are available as of a
-21-
date not more than five business days prior to the date of such letter; provided, however,
that, with respect to any financial information or other matters, such letter may reconfirm as true
and correct at such date as though made at and as of such date, rather than repeat, statements with
respect to such financial information or other matters made in the letter referred to in Section
5.01(g) hereof that was last furnished to DBSI; provided, however, that the Company shall have the
right in its sole discretion to suspend the delivery of any such letter otherwise required by this
Section 4.08 if the Company does not expect to deliver an Issuance Notice with respect to the
Common Shares; and provided, further, that the delivery of each such
letter (dated on or prior to the date of such Issuance Notice) required by this Section 4.08 shall be a condition precedent to the delivery
by the Company of an Issuance Notice with respect to the Common Shares;
Section 4.09.
Officers’ Certificate. (i) Prior to or at the first delivery of an
Issuance Notice, and each time the Registration Statement or the Prospectus is amended or
supplemented (other than by an amendment or supplement relating solely to the offering of
securities other than the Common Shares issued or issuable pursuant to the Sales Agency Agreements,
an Issuance Supplement or a Current Report on Form 8-K, unless reasonably requested by DBSI within
five days of the filing thereof with the Commission), including by means of an Annual Report on
Form 10-K or a Quarterly Report on Form 10-Q filed with the Commission under the Exchange Act and
incorporated or deemed to be incorporated by reference into the Prospectus or (ii) after each
reasonable request by DBSI (each date of any such request by DBSI, an “Officers’ Certificate Request
Date”), the Company shall as soon as practicable thereafter furnish or cause to be furnished to DBSI
a certificate, dated the date of such supplement, amendment or incorporation, as the case may be,
in such form and executed by such officers of the Company as is reasonably satisfactory to DBSI, of
the same tenor as the certificate referred to in Section 2.02(ii) but modified to relate to the
Registration Statement, the Prospectus and the General Disclosure Package (other than the offering
price of any Common Shares) as amended and supplemented to such date; provided, however, that the
Company shall have the right in its sole discretion to suspend the delivery of any such certificate
otherwise required by this Section 4.09 if the Company does not expect to deliver an Issuance
Notice with respect to the Common Shares; and provided, further, that the delivery of each such
certificate (dated on or prior to the date of such Issuance Notice) required by this Section 4.09 shall be a condition
precedent to the delivery by the Company of an Issuance Notice with respect to the Common Shares;
Section 4.10. Stand Off Agreement. Without the written consent of DBSI, during the
period beginning on the first Trading Day immediately prior to the date on which any Issuance
Notice is delivered to DBSI hereunder and ending on the first Trading Day immediately following the
Settlement Date with respect to Common Shares sold pursuant to such Issuance Notice (each a “Stand
Off Period”), the Company will not, directly or indirectly, offer, sell, agree to offer or sell,
solicit offers to purchase, grant any call option or purchase any put option with respect to,
pledge, borrow or otherwise dispose of any Relevant Security (as defined below), or establish or
increase any “put equivalent position” or liquidate or decrease any “call equivalent position” with
respect to any Relevant Security (in each case within the meaning of Section 16 of the Exchange Act
and the rules and regulations of the Commission thereunder), or otherwise enter into any swap,
derivative or other transaction or arrangement that transfers to another, in whole or in part, any
economic consequence of ownership of a Relevant Security, whether or not
-22-
such transaction is to be settled by delivery of Relevant Securities, other securities, cash
or other consideration; provided that the foregoing shall not restrict the issuance of Relevant
Securities (x) upon issuances (A) pursuant to equity-based awards granted in the ordinary course of
business to trustees or employees of the Company or the Operating Partnership, (B) upon exercise of
options or warrants and upon conversion, exchange or redemption of convertible, exchangeable or
redeemable securities, in each case which were granted pursuant to clause (A) above or were
outstanding as of the date of the latest audited financial statements included or incorporated by
reference in the Registration Statement and the Prospectus, (C) upon the exchange of Operating
Partnership interests for beneficial interests in the Company or upon exchange of any of the 3.875%
exchangeable guaranteed notes due 2026 issued by the Operating Partnership, and (D) upon issuances
of Common Shares pursuant to this Agreement, and (y) repurchases of the Company’s beneficial
interests under the Company’s share repurchase program). As used in this Section 4.10, the term
“Relevant Security” means the Common Shares, any other equity security of the Company or any of its
subsidiaries and any security convertible into, or exercisable or exchangeable for, any Common
Shares or other such equity security. Notwithstanding the foregoing, the settlement of Common
Shares which have been sold pursuant to the Alternative Sales Agency Agreements shall be permitted
pursuant to this Section 4.10 without the consent of DBSI;
Section 4.11. Market Activities. The Company will not, directly or indirectly, (i)
take any action designed to cause or result in, or that constitutes or might reasonably be expected
to constitute, the stabilization or manipulation of the price of any security of the Company or the
Operating Partnership to facilitate the sale or resale of the Common Shares or (ii) during any
Stand Off Period sell, bid for or purchase the Common Shares, or pay any person any compensation
for soliciting purchases of the Common Shares other than DBSI or an Alternative Sales Agent;
Section 4.12. Prospectus Supplement Filing; Periodic Reports. Promptly following the
end of each quarterly period, the Company shall be required to file a prospectus supplement with
the Commission, disclosing the number of Common Shares sold through DBSI and the Alternative Sales
Agents under the Sales Agency Agreements and the net proceeds received by the Company with respect
to sales of the Common Shares pursuant to the Sales Agency Agreements relating to such quarter,
together with any other information that the Company reasonably believes is required to comply with
the Securities Act or any rules or regulations thereunder. In the alternative, to the extent
permitted by the rules and regulations of the SEC, the Company in its sole discretion may make the
disclosures contemplated by the preceding sentence by including such disclosures in its Annual
Report on Form 10-K or Quarterly Report on Form 10-Q filed by the Company for any quarter in which
sales of Common Shares were made by or through DBSI and the Alternative Sales Agents under the Sales
Agency Agreements;
Section 4.13. Maximum Program Amount. The Company will promptly notify DBSI and the
Alternative Sales Agents when the Maximum Program Amount has been sold pursuant to the Sales Agency
Agreements; and
Section 4.14. Due Diligence. The Company shall promptly reply to due diligence
inquiries from DBSI, including, without limitation, furnishing requested materials and making
-23-
senior management available for due diligence conference calls and using commercially
reasonable efforts to have its independent registered public accounting firm available to
participate in due diligence conference call, upon the reasonable request of DBSI.
ARTICLE V
CONDITIONS TO DELIVERY OF ISSUANCE
NOTICES AND TO SETTLEMENT
CONDITIONS TO DELIVERY OF ISSUANCE
NOTICES AND TO SETTLEMENT
Section 5.01. Conditions Precedent to the Right of the Company to Deliver an Issuance
Notice and the Obligation of DBSI to Sell Common Shares During the Selling Period(s). The right
of the Company to deliver an Issuance Notice hereunder is subject to the satisfaction, on the date
of delivery of such Issuance Notice, and any obligation of DBSI to sell Common Shares during the
applicable Selling Period shall be subject to the satisfaction, on the applicable Settlement Date,
of each of the following conditions:
(a) Effective Registration Statement and Authorizations. The Registration Statement
shall remain effective and sales of all of the Common Shares (including all of the Issuance Shares
issued with respect to all prior Issuances and all of the Issuance Shares expected to be issued in
connection with the Issuance specified by the current Issuance Notice) may be made by DBSI
thereunder, and (i) no stop order suspending the effectiveness of the Registration Statement shall
have been issued and no proceeding for that purpose shall have been initiated or threatened by the
Commission; (ii) no other suspension of the use or withdrawal of the effectiveness of the
Registration Statement or Prospectus shall exist; (iii) all requests for additional information on
the part of the Commission shall have been complied with to the reasonable satisfaction of DBSI; and
(iv) no event specified in Section 4.03 hereof shall have occurred and be continuing without the
Company amending or supplementing the Registration Statement or the Prospectus as provided in
Section 4.03. The authorizations referred to in Section 3.10 of this Agreement shall have been
issued and shall be in full force and effect, and such authorizations shall not be the subject of
any pending or threatened application for rehearing or petition for modification, and are
sufficient to authorize the issuance and sale of the Common Shares.
(b) Accuracy of Representations and Warranties of the Company and the Operating
Partnership. The representations and warranties of the Company and the Operating Partnership
shall be true and correct as of each Applicable Time, as of the Closing Date, as of the applicable
date referred to in Section 4.09 that is prior to such Issuance Date or Settlement Date, as the
case may be, and as of such Issuance Date and Settlement Date as though made at such time.
(c) Performance by the Company and the Operating Partnership. The Company shall have
performed, satisfied and complied with all covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Company or the Operating Partnership,
as the case may be, at or prior to such date.
(d) No Injunction. No statute, rule, regulation, executive order, decree, ruling or
injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental
authority of competent jurisdiction or any self-regulatory organization
-24-
having authority over the matters contemplated hereby that prohibits or directly and
materially adversely affects any of the transactions contemplated by this Agreement, and no
proceeding shall have been commenced that may have the effect of prohibiting or materially
adversely affecting any of the transactions contemplated by this Agreement.
(e) Material Adverse Changes. Since the date of this Agreement, no event that had or
is reasonably likely to have a Material Adverse Effect shall have occurred that has not been
disclosed in the Registration Statement, the Prospectus or the General Disclosure Package
(including, without limitation, the documents incorporated by reference therein and any supplements
thereto).
(f) No Suspension of Trading In or Delisting of Common Shares of Beneficial Interest;
Other Events. The trading of the Common Shares of Beneficial Interest (including, without
limitation, the Issuance Shares) shall not have been suspended by the Commission, the Principal
Market or the Financial Industry Regulatory Authority since the immediately preceding Settlement
Date or, if there has been no Settlement Date, the Closing Date, and the Common Shares (including
without limitation the Issuance Shares) shall have been approved for listing or quotation on,
subject to notice of issuance, and shall not have been delisted from the Principal Market. There
shall not have occurred (and be continuing in the case of occurrences under clauses (i) and (ii)
below) any of the following: (i) trading generally on the Principal Market or The Nasdaq Stock
Market has been suspended or materially limited, or minimum and maximum prices for trading have
been fixed, or maximum ranges for prices have been required, by any of said exchanges or by such
system or by order of the Commission, the Financial Industry Regulatory Authority or any other
governmental authority, or a material disruption has occurred in commercial banking or securities
settlement or clearance services in the United States; (ii) a general moratorium on commercial
banking activities in New York declared by either federal or New York state authorities; or (iii)
any material adverse change in the financial markets in the United States or in the international
financial markets, any outbreak or escalation of hostilities or other calamity or crisis involving
the United States or the declaration by the United States of a national emergency or war or any
change or development involving a prospective change in national or international political,
financial or economic conditions, if the effect of any such event specified in this clause (iii) in
the sole judgment of DBSI makes it impracticable or inadvisable to proceed with the sale of Common
Shares.
(g) Comfort Letter. PricewaterhouseCoopers LLP, the independent registered public
accounting firm which has audited the consolidated financial statements of the Company and the
Operating Partnership included or incorporated by reference in the Registration Statement shall
have furnished to DBSI a comfort letter,
dated on or prior to the date of such Issuance Notice pursuant to Section 4.08, and an additional
comfort letter that is dated on or prior to such Settlement Date if the Company files a Form 10-K,
Form 10-Q or, if applicable, Form 8-K, with the SEC on or after the date of such Issuance Date
but prior to such Settlement Date, in form and substance satisfactory to DBSI to the effect required by Section 4.08.
(h) No Defaults. The execution and delivery of this Agreement and the issuance and
sale of the Common Shares and the compliance by the Company with all of the provisions of this
Agreement will not result in the Company, the Operating Partnership or any subsidiary being in
default of (whether upon the passage of time, the giving of notice or both) its organizational and
other governing documents, or any provision of any security issued by the
-25-
Company, the Operating Partnership or subsidiary, or of any agreement, instrument or other
undertaking to which the Company, the Operating Partnership or subsidiary is a party or by which it
or any of its property or assets is bound, or the applicable provisions of any law, statute, rule,
regulation, order, writ, injunction, judgment or decree of any court or governmental authority to
or by which the Company, the Operating Partnership or subsidiary or any of their property or assets
are bound, in each case which default, either individually or in the aggregate, could reasonably be
expected to have a Material Adverse Effect.
(i) Trading Cushion. The Selling Period for any previous Issuance Notice shall have
expired.
(j) Maximum Issuance Shares. In no event may the Company issue an Issuance Notice to
sell a number of Issuance Shares to the extent that the sum of (x) the number of Issuance Shares
requested in such Issuance Notice, plus (y) the aggregate number of all Common Shares issued under
all previous Issuances effected pursuant to this Agreement, together with the aggregate number of
Common Shares issued under the Alternative Sales Agency Agreements, would exceed the Maximum
Program Amount.
(k) Prospectus Supplement and Issuance Supplement.
(1) A supplement to the prospectus included in the Registration
Statement (the “Prospectus
Supplement”), in form and substance to be agreed upon by the parties hereto, setting forth
information regarding this Agreement, including, without limitation, the Maximum Program Amount,
shall have been filed with the Commission pursuant to Rule 424(b) promulgated by the Commission
under the Securities Act within the time period required thereby and sufficient copies thereof
delivered to DBSI prior to or on the Issuance Date.
(2) To the extent required by Section 4.01(ii), an Issuance
Supplement, in form and substance
to be agreed upon by the parties, shall have been filed with the Commission pursuant to Rule 424(b)
promulgated by the Commission under the Securities Act within the time period required thereby and
sufficient copies thereof delivered to DBSI prior to or on the Issuance Date.
(l) Opinions of Counsel. Xxxxxx Xxxxxxxx LLP, counsel to the Company and the
Operating Partnership, or other counsel selected by the Company and reasonably satisfactory to DBSI
shall have furnished to DBSI their written opinion,
dated on or prior to the date of such Issuance Notice pursuant to Section 4.07, and an additional
written opinion that is dated on or prior to such Settlement Date if the Company files a Form 10-K, Form 10-Q or, if applicable, Form 8-K, with the SEC on or after the date of such Issuance
Notice but prior to such Settlement Date,
to the effect required by Section 4.07.
(m) Officers’ Certificate. The Company shall have furnished or caused to be
furnished
to DBSI an officers’ certificate executed by the President and Chief Executive Officer of the
Company or by the Executive Vice President and Chief Financial Officer of the Company, signing in
their respective capacities,
dated on or prior to the date of such Issuance Notice pursuant to Section 4.09, and an additional
officers’ certificate that is dated on or prior to such Settlement Date if the Company files a Form
10-K, Form 10-Q or, if applicable, Form 8-K, with the SEC on or after the date of such Issuance
Notice but prior to such Settlement Date, as to the
matters specified in Section 2.02(ii).
(n) Other Documents. On the Closing Date and prior to such Issuance Date or
Settlement Date, as the case may be, DBSI and its counsel shall have been furnished with
-26-
such documents as they may reasonably require in order to evidence the accuracy and
completeness of any of the representations or warranties, or the fulfillment of the conditions,
herein contained; and all proceedings taken by the Company in connection with the issuance and sale
of the Common Shares as herein contemplated shall be satisfactory in form and substance to DBSI and
Xxxxxxx Xxxxxxx & Xxxxxxxx LLP, counsel to DBSI and the Alternative Sales Agents.
Section 5.02. Suspension of Sales. The Company or DBSI may, upon notice to the other
party in writing or by telephone (confirmed immediately by verifiable facsimile transmission),
suspend any sale of Issuance Shares, and the Selling Period shall immediately terminate; provided,
however, that such suspension and termination shall not affect or impair either party’s obligations
with respect to any Issuance Shares sold hereunder prior to the receipt of such notice. The
Company agrees that no such notice shall be effective against DBSI unless it is made to one of the
individuals named on Schedule 1 hereto, as such Schedule may be amended from time to time. DBSI
agrees that no such notice shall be effective against the Company unless it is made to one of the
individuals named on Schedule 1 annexed hereto, as such Schedule may be amended from time to time.
ARTICLE VI
INDEMNIFICATION AND CONTRIBUTION
INDEMNIFICATION AND CONTRIBUTION
Section 6.01. Indemnification by the Company and the Operating Partnership. The
Company and the Operating Partnership, jointly and severally, agree to indemnify and hold harmless
DBSI, its officers, directors, employees and agents, and each Person, if any, who controls DBSI
within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, together
with each such Person’s respective officers, directors, employees and agents (collectively, the
“Controlling Persons”), from and against any and all losses, claims, damages or liabilities, and
any action or proceeding in respect thereof, to which DBSI, its officers, directors, employees and
agents, and any such Controlling Person may become subject under the Securities Act, the Exchange
Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions or proceedings
in respect thereof) arise out of, or are based upon, any untrue statement or alleged untrue
statement of a material fact contained in the Registration Statement, the Prospectus or any other
prospectus relating to the Common Shares, or any amendment or supplement thereto, any preliminary
prospectus or any Issuer Free Writing Prospectus or any “issuer information” filed or required to
be filed pursuant to Rule 433(d) under the Securities Act, or arise out of, or are based upon, any
omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statements therein (in the case of the Prospectus or any amendment or
supplement thereto, or any preliminary prospectus, or any Issuer Free Writing Prospectus, in light
of the circumstances in which they were made) not misleading, except insofar as the same are made
in reliance upon and in conformity with information related to DBSI furnished in writing to the
Company by DBSI expressly for use therein, and the Company and the Operating Partnership, jointly
and severally, shall reimburse DBSI, its officers, directors, employees and agents, and each
Controlling Person for any reasonable legal and other expenses incurred thereby in investigating or
defending or preparing to defend against any such losses, claims, damages or liabilities, or
actions or proceedings in respect thereof, as such expenses are incurred.
-27-
Section 6.02. Indemnification by DBSI. DBSI agrees to indemnify and hold harmless the
Company and the Operating Partnership, and their respective officers, trustees, employees and
agents and each Person, if any, who controls the Company or the Operating Partnership within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, together with each
such Person’s respective officers, trustees, employees and agents, from and against any losses,
claims, damages or liabilities, and any action or proceeding in respect thereof, to which the
Company or the Operating Partnership, their respective officers, trustees, employees or agents, any
such controlling Person and any officer, trustee, employee or agent of such controlling Person may
become subject under the Securities Act, the Exchange Act or otherwise, insofar as losses, claims,
damages or liabilities (or action or proceeding in respect thereof) arise out of, or are based
upon, any untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement, the Prospectus or any other prospectus relating to the Common Shares, or
any amendment or supplement thereto, any preliminary prospectus or any Issuer Free Writing
Prospectus, or arise out of, or are based upon, any omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements therein (in the
case of the Prospectus or any other prospectus relating to the Common Shares, or any amendment or
supplement thereto, any preliminary prospectus or any Issuer Free Writing Prospectus, in light of
the circumstances in which they were made) not misleading in each case to the extent, but only to
the extent that such untrue statement or alleged untrue statement or omission or alleged omission
was made therein in reliance upon and in conformity with written information related to DBSI
furnished to the Company by or on behalf of DBSI expressly for use therein, and DBSI shall reimburse
the Company and the Operating Partnership, their respective officers, trustees, directors,
employees and agents, and each Controlling Person of the Company or the Operating Partnership, for
any reasonable legal and other expenses incurred thereby in investigating or defending or preparing
to defend against any such losses, claims, damages or liabilities, or actions or proceedings in
respect thereof.
Section 6.03. Conduct of Indemnification Proceedings. Promptly after receipt by any
Person (an “Indemnified Party”) of notice of any claim or the commencement of any action in respect
of which indemnity may be sought pursuant to Section 6.01 or 6.02, the Indemnified Party shall, if
a claim in respect thereof is to be made against the Person against whom such indemnity may be
sought (an “Indemnifying Party”), notify the Indemnifying Party in writing of the claim or the
commencement of such action. In the event an Indemnified Party shall fail to give such notice as
provided in this Section 6.03 and the Indemnifying Party to whom notice was not given was unaware
of the proceeding to which such notice would have related and was materially prejudiced by the
failure to give such notice, the indemnification provided for in Sections 6.01 or 6.02 shall be
reduced to the extent of any actual prejudice resulting from such failure to so notify the
Indemnifying Party; provided, that the failure to notify the Indemnifying Party shall not relieve
it from any liability that it may have to an Indemnified Party otherwise than under Section 6.01 or
6.02. If any such claim or action shall be brought against an Indemnified Party, the Indemnifying
Party shall be entitled to participate therein, and, to the extent that it wishes, jointly with any
other similarly notified Indemnifying Party, to assume the defense thereof with counsel reasonably
satisfactory to the Indemnified Party. After notice from the Indemnifying Party to the Indemnified
Party of its election to assume the defense of such claim or action, the Indemnifying Party shall
not be liable to the Indemnified Party for any legal or other expenses subsequently incurred by the
Indemnified Party in connection with the defense
-28-
thereof other than reasonable costs of investigation; provided that the Indemnified Party
shall have the right to employ separate counsel to represent the Indemnified Party, but the fees
and expenses of such counsel shall be for the account of such Indemnified Party unless (i) the
Indemnifying Party and the Indemnified Party shall have mutually agreed to the retention of such
counsel or (ii) such Indemnified Party reasonably concludes that representation of both parties by
the same counsel would be inappropriate due to actual or potential conflicts of interest with the
Company and the Operating Partnership, it being understood, however, that the Indemnifying Party
shall not, in connection with any one such claim or action or separate but substantially similar or
related claims or actions in the same jurisdiction arising out of the same general allegations or
circumstances, be liable for the fees and expenses of more than one separate firm of attorneys
(together with appropriate local counsel) at any time for all Indemnified Parties or for fees and
expenses that are not reasonable. No Indemnifying Party shall, without the prior written consent of
the Indemnified Party, effect any settlement of any claim or pending or threatened proceeding in
respect of which the Indemnified Party is or could have been a party and indemnification could have
been sought hereunder by such Indemnified Party unless such settlement includes an unconditional
release of each such Indemnified Party from all losses, claims, damages or liabilities arising out
of such claim or proceeding and such settlement does not admit or constitute an admission of fault,
guilt, failure to act or culpability on the part of any such Indemnified Party. Whether or not the
defense of any claim or action is assumed by an Indemnifying Party, such Indemnifying Party will
not be subject to any liability for any settlement made without its prior written consent, which
consent will not be unreasonably withheld.
Section 6.04. Contribution. If for any reason the indemnification provided for in
this Article VI is unavailable to the Indemnified Parties in respect of any losses, claims, damages
or liabilities referred to herein, then each Indemnifying Party, in lieu of indemnifying such
Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a
result of such losses, claims, damages or liabilities as between the Company and the Operating
Partnership, on the one hand, and DBSI, on the other hand, in such proportion as is appropriate to
reflect the relative benefits received by the Company and the Operating Partnership, on the one
hand, and DBSI, on the other hand, from the offering of the Common Shares to which such losses,
claims, damages or liabilities relate. If, however, the allocation provided by the immediately
preceding sentence is not permitted by applicable law, then each Indemnifying Party shall
contribute to such amount paid or payable by such Indemnifying Party in such proportion as is
appropriate to reflect not only such relative benefits but also the relative fault of the Company
and the Operating Partnership and of DBSI in connection with such statements or omissions, as well
as any other relevant equitable considerations. The relative benefits received by the Company and
the Operating Partnership, on the one hand, and by DBSI, on the other, shall be deemed to be in the
same proportion as the total net proceeds from the sale of Common Shares (before deducting
expenses) received by the Company bear to the total commissions received by DBSI in respect thereof.
The relative fault of the Company and the Operating Partnership, on the one hand, and of DBSI, on
the other hand, shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission or alleged omission to state a material
fact relates to information supplied by the Company and the Operating Partnership, on one hand, or
by DBSI, on the other hand, and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission.
-29-
The Company, the Operating Partnership and DBSI agree that it would not be just and equitable
if contribution pursuant to this Section 6.04 were determined by pro rata allocation or by any
other method of allocation that does not take account of the equitable considerations referred to
in the immediately preceding paragraph. The amount paid or payable by an Indemnified Party as a
result of the losses, claims, damages or liabilities referred to in the immediately preceding
paragraph shall be deemed to include, subject to the limitations set forth above, any reasonable
legal or other expenses reasonably incurred by such Indemnified Party in connection with
investigating or defending any such action or claim. Notwithstanding the provisions of this
Section 6.04, DBSI shall in no event be required to contribute any amount in excess of the
commissions received by it under this Agreement. No Person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from
any Person who was not guilty of such fraudulent misrepresentation. For purposes of this Section
6.04 each officer, director, employee and agent of DBSI, and each Controlling Person of DBSI, shall
have the same rights to contribution as DBSI, and each officer, trustee, employee and agent of the
Company or the Operating Partnership, and each Controlling Person of the Company or the Operating
Partnership, shall have the same rights to contribution as the Company and the Operating
Partnership. The obligations of the Company, the Operating Partnership and DBSI under this Article
VI shall be in addition to any liability that any such party may otherwise have.
ARTICLE VII
TERMINATION
TERMINATION
Section 7.01. Term. Subject to the provisions of this Article VII, the term of this
Agreement shall run until the end of the Commitment Period.
Section 7.02. Termination by DBSI. DBSI may terminate the right of the Company to
effect any Issuances under this Agreement:
(a) upon
one Trading Day’s notice if any of the following events shall occur:
(i) the Company or any subsidiary shall make an assignment for
the benefit of creditors, or
apply for or consent to the appointment of a receiver or trustee for it or for all or substantially
all of its property or business; or such a receiver or trustee shall otherwise be appointed;
(ii) bankruptcy, insolvency, reorganization or liquidation
proceedings or other proceedings
for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or
against the Company or any of its subsidiaries;
(iii) the Company shall fail to maintain the listing of the
Common Stock on the Principal
Markets; or
(iv) since the Effective Date, there shall have occurred any
event, development or
circumstances or facts relating to the Company, the Operating Partnership or any other subsidiary
of the Company that has had or could reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect; or
-30-
(b) otherwise upon ten days’ notice of its election to terminate this Agreement, in its
sole
discretion, at any time.
Section 7.03. Termination by the Company. The Company shall have the right, by giving
ten Trading Days’ notice as hereinafter specified, to terminate this Agreement in its sole
discretion at any time. After delivery of such notice, the Company shall no longer have any right
to deliver any Issuance Notices hereunder.
Section 7.04. Liability; Provisions that Survive Termination. If this Agreement is
terminated pursuant to this Article VII, such termination shall be without liability of any party
hereto to any other party hereto except as provided in Section 9.02 and for the Company’s
obligations in respect of all prior Issuance Notices, and provided further that in any case the
provisions of Article VI, Article VIII and Article IX shall survive termination of this Agreement
without limitation.
ARTICLE VIII
REPRESENTATIONS AND WARRANTIES TO SURVIVE DELIVERY
REPRESENTATIONS AND WARRANTIES TO SURVIVE DELIVERY
All representations and warranties of the Company and the Operating Partnership herein or in
certificates delivered pursuant hereto shall remain operative and in full force and effect
regardless of (i) any investigation made by or on behalf of DBSI and its officers, directors,
employees and agents and any Controlling Persons, (ii) delivery and acceptance of the Common Shares
and payment therefor or (iii) any termination of this Agreement.
ARTICLE IX
MISCELLANEOUS
MISCELLANEOUS
Section 9.01. Press Releases and Disclosure. The Company may issue a press release
describing the material terms of the transactions contemplated hereby as soon as practicable
following the Closing Date, and may file with the Commission a Current Report on Form 8-K
describing the material terms of the transactions contemplated hereby, and the Company shall
consult with DBSI prior to making such disclosures, and the parties shall use all commercially
reasonable efforts, acting in good faith, to agree upon a text for such disclosures that is
reasonably satisfactory to all parties. No party hereto shall issue thereafter any press release or
like public statement (including, without limitation, any disclosure required in reports filed
with the Commission pursuant to the Exchange Act) related to this Agreement or any of the
transactions contemplated hereby without the prior written approval of the other party hereto,
except as may be necessary or appropriate in the opinion of the party seeking to make disclosure to
comply with the requirements of applicable law or stock exchange rules. If any such press release
or like public statement is so required, the party making such disclosure shall consult with the
other party prior to making such disclosure, and the parties shall use all commercially reasonable
efforts, acting in good faith, to agree upon a text for such disclosure that is reasonably
satisfactory to all parties.
Section 9.02. Expenses. The Company covenants and agrees with DBSI that the Company
shall pay or cause to be paid the following: (i) the fees, disbursements and expenses of the
Company’s counsel and independent registered public accounting firm in connection with the
-31-
preparation, printing and filing of the Registration Statement, the Prospectus and any
Issuance Supplements and all other amendments and supplements thereto and the mailing and
delivering of copies thereof to DBSI and the Principal Exchanges; (ii) initial reasonable documented
fees, disbursements and expenses of counsel of DBSI and the Alternative Sales Agents (including in
connection with the qualification of the Common Shares for offering and sale under state securities
laws as provided in Section 4.02 hereof and in connection with preparing any blue sky survey), in
connection with this Agreement and the Registration Statement (not to exceed $100,000 plus the
reasonable disbursements and expenses of such counsel); (iii) the cost (other than those expenses
described in clause (ii) above) of printing, preparing or reproducing this Agreement and any other
documents in connection with the offering, purchase, sale and delivery of the Common Shares; (iv)
all filing fees and expenses (other than those expenses described in clause (ii) above) in
connection with the qualification of the Common Shares for offering and sale under state securities
laws as provided in Section 4.02 hereof; (v) the cost of preparing the Common Shares; (vi) the fees
and expenses of any transfer agent of the Company; (vii) the cost of providing any CUSIP or other
identification numbers for the Common Shares; (viii) the fees and expenses incurred in connection
with the listing or qualification of the Common Shares on the Principal Market and any filing fees
incident to any required review by the Financial Industry Regulatory Authority of the terms of the
sale of the Common Shares in connection with this Agreement and the Registration Statement
(including the reasonable fees, disbursements and expenses of counsel for DBSI), and (ix) all other
costs and expenses incident to the performance of the Company’s obligations hereunder that are not
otherwise specifically provided for in this Section. During the term of this Agreement, the
Company shall pay the fees of counsel to DBSI and the other Sales Agents for its quarterly due
diligence review (with the amount for such counsel not to exceed $10,000 plus reasonable
disbursements and expenses per fiscal quarter or such higher amount as shall be agreed in good
faith between the Company and DBSI in light of the relevant circumstances in such fiscal quarter).
Section 9.03. Notices. All notices, demands, requests, consents, approvals or other
communications required or permitted to be given hereunder or that are given with respect to this
Agreement shall be in writing and shall be personally served or deposited in the mail, registered
or certified, return receipt requested, postage prepaid or delivered by reputable air courier
service with charges prepaid, or transmitted by hand delivery, telegram, telex or facsimile,
addressed as set forth below, or to such other address as such party shall have specified most
recently by written notice: (i) if to the Company or the Operating Partnership, addressed to them
at: 000 Xxxx Xxxxxxxxx Xxxxxx, Xxxxxx, Xxxxxxxxxxxx 00000, Attention: Chief Financial Officer,
Facsimile No.: (000) 000-0000 and Attention: Legal Department, Facsimile No. (000) 000-0000, with a
copy (which shall not constitute notice) to: Xxxxxx Xxxxxxxx LLP, 3000 Two Xxxxx Square, Eighteenth
and Xxxx Xxxxxxx, Xxxxxxxxxxxx, Xxxxxxxxxxxx 00000, Attention Xxxxxxx X. Xxxxxxxx, Esq., Facsimile
No.: (000) 000-0000; and (ii) if to DBSI, Deutsche Bank Securities Inc., 00 Xxxx Xxxxxx, 0xx xxxxx,
Xxx Xxxx, Xxx Xxxx, 00000, Attn: Xxxxx X. Xxxxxxx and Xxxxxx Xxxxxxxx. Facsimile No.: (000) 000-0000.
Except as set forth in Section 5.03, notice shall be deemed given on the date of service or
transmission if personally served or transmitted by telegram, telex or confirmed facsimile. Notice
otherwise sent as provided herein shall be deemed given on the third business day following the
date mailed or on the next business day following delivery of such notice to a reputable air
courier service for next day delivery.
-32-
Section 9.04. Entire Agreement. This Agreement constitutes the entire agreement of
the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous
agreements, representations, understandings, negotiations and discussions between the parties,
whether oral or written, with respect to the subject matter hereof.
Section 9.05. Amendment and Waiver. This Agreement may not be amended, modified,
supplemented, restated or waived except by a writing executed by the party against which such
amendment, modification, supplement, restatement or waiver is sought to be enforced. Waivers may
be made in advance or after the right waived has arisen or the breach or default waived has
occurred. Any waiver may be conditional. No waiver of any breach of any agreement or provision
herein contained shall be deemed a waiver of any preceding or succeeding breach thereof nor of any
other agreement or provision herein contained. No waiver or extension of time for performance of
any obligations or acts shall be deemed a waiver or extension of the time for performance of any
other obligations or acts.
Section 9.06. No Assignment; No Third Party Beneficiaries. This Agreement and the
rights, duties and obligations hereunder may not be assigned or delegated by the Company or the
Operating Partnership or by DBSI. Any purported assignment or delegation of rights, duties or
obligations hereunder shall be void and of no effect. This Agreement and the provisions hereof
shall be binding upon and shall inure to the benefit of each of the parties and their respective
successors and, to the extent provided in Article VI, the controlling persons, officers, trustees,
directors, employees and agents referred to in Article VI. This Agreement is not intended to
confer any rights or benefits on any Persons other than as set forth in Article VI or elsewhere in
this Agreement.
Section 9.07. Severability. This Agreement shall be deemed severable, and the
invalidity or unenforceability of any term or provision hereof shall not affect the validity or
enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of
any such invalid or unenforceable term or provision, the parties hereto intend that there shall be
added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable
provision as may be possible and be valid and enforceable.
Section 9.08. Further Assurances. Each party hereto, upon the request of any other
party hereto, shall do all such further acts and execute, acknowledge and deliver all such further
instruments and documents as may be necessary or desirable to carry out the transactions
contemplated by this Agreement.
Section 9.09. Titles and Headings. Titles, captions and headings of the sections of
this Agreement are for convenience of reference only and shall not affect the construction of any
provision of this Agreement.
Section 9.10. Governing Law; Jurisdiction. THIS AGREEMENT SHALL BE GOVERNED BY,
INTERPRETED UNDER AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF NEW YORK
APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED WITHIN THE STATE OF NEW YORK WITHOUT GIVING
EFFECT TO PRINCIPLES OF CONFLICTS OF LAWS THEREOF. Any action, suit or proceeding to enforce any
provision of, or based on any matter arising out of or in
-33-
connection with, this Agreement or the transactions contemplated hereby shall be brought in
any federal court located in the Southern District of the State of New York or any New York state
court located in the Borough of Manhattan, and the Company agrees to the exclusive jurisdiction of
such courts (and of the appropriate appellate courts therefrom) and each party waives (to the full
extent permitted by law) any objection it may have to the laying of venue of any such suit, action
or proceeding in any such court or that any such suit, action or proceeding has been brought in an
inconvenient forum.
Section 9.11. Waiver of Jury Trial. The Company, the Operating Partnership and DBSI
each hereby irrevocably waives any right it may have to a trial by jury in respect of any claim
based upon or arising out of this Agreement or any transaction contemplated hereby.
Section 9.12. Counterparts. This Agreement may be executed in one or more
counterparts, each of which shall be deemed an original, and all of which taken together shall
constitute one and the same instrument. Delivery of an executed Agreement by one party to the
other may be made by facsimile transmission.
Section 9.13. Adjustments for Share Splits, etc. The parties acknowledge and agree
that share related numbers contained in this Agreement (including the minimum Floor Price) shall be
equitably adjusted to reflect share splits, share dividends, reverse share splits, combinations and
similar events.
Section 9.14. No Fiduciary Duty. The Company and the Operating Partnership
acknowledge and agree that DBSI is acting solely in the capacity of an arm’s length contractual
counterparty to the Company with respect to the offering of Common Shares contemplated hereby
(including in connection with determining the terms of the offering) and not as a financial advisor
or a fiduciary to, or an agent of, the Company or the Operating Partnership or any other person and
will not claim that DBSI is acting in such capacity in connection with the offering of the Common
Shares contemplated hereby. Additionally, DBSI is not advising the Company or the Operating
Partnership or any other person as to any legal, tax, investment, accounting or regulatory matters
in any jurisdiction with respect to the offering of Common Shares contemplated hereby. The Company
and the Operating Partnership shall consult with their own advisors concerning such matters and
shall be responsible for making their own independent investigation and appraisal of the
transactions contemplated hereby, and DBSI shall have no responsibility or liability to the Company
or the Operating Partnership with respect thereto. Any review by DBSI of the Company, the Operating
Partnership, the transactions contemplated hereby or other matters relating to such transactions
will be performed solely for the benefit of DBSI and shall not be on behalf of the Company or the
Operating Partnership.
[Signature page follows]
-34-
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by the undersigned, thereunto duly authorized, as of the date first set forth above.
| BRANDYWINE REALTY TRUST |
||||
| By: | /s/ Xxxxxx X. Xxxxxxx | |||
| Name: | Xxxxxx X. Xxxxxxx | |||
| Title: | President and Chief Executive Officer | |||
| BRANDYWINE OPERATING PARTNERSHIP, L.P. |
||||
| By: | Brandywine Realty Trust, its General Partner | |||
| By: | /s/ Xxxxxx X. Xxxxxxx | |||
| Name: | Xxxxxx X. Xxxxxxx | |||
| Title: | President and Chief Executive Officer | |||
| DEUTSCHE BANK SECURITIES INC. |
||||
| By: | /s/ Xxxxx Xxxxxx | |||
| Name: Xxxxx Xxxxxx | ||||
| Title: Managing Director | ||||
| By: | /s/ Xxxxxx Xxx | |||
| Name: Xxxxxx Xxx | ||||
| Title: Managing Director | ||||
EXHIBIT A
ISSUANCE NOTICE
[DATE]
Deutsche Bank Securities Inc.
00 Xxxx Xxxxxx, 0xx xxxxx
Xxx Xxxx, XX 00000
Attn: Xxxxx X. Xxxxxxx
Xxxxxx Xxxxxxxx
00 Xxxx Xxxxxx, 0xx xxxxx
Xxx Xxxx, XX 00000
Attn: Xxxxx X. Xxxxxxx
Xxxxxx Xxxxxxxx
Reference is made to the Sales Agency Financing Agreement among Brandywine Realty Trust (the
“Company”), Brandywine Operating Partnership, L.P. (the “Operating Partnership”) and Deutsche Bank
Securities Inc. dated as of March 10, 2010. The Company confirms that all conditions to the
delivery of this Issuance Notice are satisfied as of the date hereof.
The Company and the Operating Partnership represent and warrant that each representation and
warranty of the Company or the Operating Partnership, as the case may be, contained in the Sales
Agency Financing Agreement is true and correct on the date hereof, and that the Registration
Statement, the Prospectus and the General Disclosure Package, including the documents incorporated
by reference therein, as of the date hereof, do not contain an untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made, not misleading.
The Company hereby certifies that all conditions to the delivery of this Issuance Notice have
been satisfied as of the date hereof.
Effective Date of Delivery of Issuance Notice (determined pursuant to Section 2.03(b)):
Number of Days in Selling Period:
First Date of Selling Period:
Last Date of Selling Period:
Settlement Date(s):
Issuance Shares:
Selling Commission: %
A-1
Floor Price Limitation (Adjustable by Company during the Selling Period, and in no event less
than $1.00 per share): $ per share
Comments:
| BRANDYWINE REALTY TRUST |
||||
| By: | ||||
| Name: | Xxxxxx X. Xxxxxxx | |||
| Title: | President and Chief Executive Officer | |||
ACKNOWLEDGED:
BRANDYWINE OPERATING PARTNERSHIP, L.P.
By: Brandywine Realty Trust, its General Partner
| By: | ||||
| Name: | Xxxxxx X. Xxxxxxx | |||
| Title: | President and Chief Executive Officer | |||
A-2
EXHIBIT B
FORM OF OPINION OF XXXXXX XXXXXXXX LLP,
COUNSEL FOR THE COMPANY
COUNSEL FOR THE COMPANY
B-1
SCHEDULE 1
DBSI
Xxxxx X. Xxxxxxx
Telephone:
|
(000) 000-0000 | |
Facsimile:
|
(000) 000-0000 | |
E-mail: |
xxxxx-x.xxxxxxx@xx.xxx | |
Address:
|
00 Xxxx Xxxxxx, 0xx Xxxxx | |
| Xxx Xxxx, XX 00000 | ||
| Xxxxxx Xxxxxxxx | ||
Telephone:
|
(000) 000-0000 | |
Facsimile:
|
(000) 000-0000 | |
E-mail: |
xxxxxx.xxxxxxxx@xx.xxx | |
Address:
|
00 Xxxx Xxxxxx, 0xx Xxxxx | |
| Xxx Xxxx, XX 00000 |
BRANDYWINE REALTY TRUST and
BRANDYWINE OPERATING PARTNERSHIP, L.P.
BRANDYWINE OPERATING PARTNERSHIP, L.P.
Xxxxxx X. Xxxxxxx
President and Chief Financial Officer
President and Chief Financial Officer
Telephone:
|
(000) 000-0000 | |
Facsimile:
|
(000) 000-0000 | |
E-mail:
|
xxxxx.xxxxxxx@xxxxxxx.xxx | |
Address:
|
000 Xxxx Xxxxxxxxx Xxxxxx | |
| Xxxxxx, Xxxxxxxxxxxx 00000 |
Xxxxxx X. Xxxxxxx
Executive Vice President and Chief Financial Officer
Executive Vice President and Chief Financial Officer
Telephone:
|
(000) 000-0000 | |
Facsimile:
|
(000) 000-0000 | |
E-mail:
|
xxxxxx.xxxxxxx@xxxxxxx.xxx | |
Address:
|
000 Xxxx Xxxxxxxxx Xxxxxx | |
| Xxxxxx, Xxxxxxxxxxxx 00000 |
S-1
